Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Compugen Ltd
(NQ:
CGEN
)
1.430
+0.020 (+1.42%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Compugen Ltd
< Previous
1
2
3
4
5
Next >
Earnings Scheduled For March 5, 2024
March 05, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via
Benzinga
Earnings Preview For Compugen
March 04, 2024
Via
Benzinga
5 Analysts Have This to Say About Compugen
August 07, 2023
Via
Benzinga
Compugen Earnings Preview
August 04, 2023
Via
Benzinga
Expert Ratings for Compugen
May 26, 2023
Via
Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
CGEN Stock Earnings: Compugen Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
CGEN stock results show that Compugen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
CGEN Stock Earnings: Compugen Misses EPS, Misses Revenue for Q1 2024
May 20, 2024
CGEN stock results show that Compugen missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
CGEN Stock Earnings: Compugen Misses EPS, Beats Revenue for Q4 2023
March 05, 2024
CGEN stock results show that Compugen missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
7 Speculative Stocks to Double Your Money THIS Year
January 22, 2024
Although terribly risky, these stocks to double your money could be enticing if you have some pocket change lying around.
Via
InvestorPlace
Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge
December 19, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 200 points on Tuesday. The Dow traded up 0.53% to 37,505.25 while the NASDAQ rose 0.51% to 14,980.71. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Compugen: Q1 Earnings Insights
May 15, 2023
Via
Benzinga
Earnings Preview: Compugen
February 24, 2023
Via
Benzinga
Why Shares of Compugen Rose on Thursday
December 29, 2022
The clinical-stage biotech retreated a bit from one of its biggest days in a while.
Via
The Motley Fool
Why Shares of Compugen Rose 16.5% on Wednesday
November 30, 2022
Market factors and a company announcement helped the stock climb.
Via
The Motley Fool
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 19, 2023
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...
Via
Benzinga
Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results
December 19, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.46% to 37,476.21 while the NASDAQ rose 0.41% to 14,966.74. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today?
December 19, 2023
Gilead Sciences Inc (NASDAQ: GILD) announced an agreement with Compugen Ltd (NASDAQ: CGEN) to license its pre-clinical antibody program against IL-18 binding protein exclusively, including the
Via
Benzinga
Why Are Stocks Up Today?
December 19, 2023
Stocks are up today and investors wondering why will want to keep reading as we have a breakdown of the market's rally on Tuesday!
Via
InvestorPlace
Why Is Compugen (CGEN) Stock Up 189% Today?
December 19, 2023
Compugen stock is up on Tuesday as investors in CGEN shares react to an exclusive licensing agreement with Gilead Sciences.
Via
InvestorPlace
US Stocks Higher; Accenture Issues Weak Sales Outlook
December 19, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining around more than 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.17% to 37,369.84 while the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 19, 2023
It's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning!
Via
InvestorPlace
7 Promising Penny Stocks With the Potential to Defy Expectations
December 15, 2023
While market speculation can get extremely dangerous, those who understand the risks may like these high-potential penny stocks.
Via
InvestorPlace
Use Support And Resistance Levels To Avoid Chaos In Your Portfolio
October 28, 2023
A support line is a price level where a stock historically stops declining. It can be a flat line all at one price, or it can be a trend line that gradually moves in one direction. Here is a closer...
Via
Talk Markets
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
Why Compugen Shares Are Up Today
February 28, 2023
The company released its fourth-quarter and full-year results after the bell Monday.
Via
The Motley Fool
Earnings Scheduled For February 27, 2023
February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.
Via
Benzinga
Why Compugen Stock Got Slammed Today
February 08, 2023
Clinical-stage biotechs are particularly susceptible to shifts in analyst sentiment.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2023
February 08, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.